TREATMENT OF LATE LYME BORRELIOSIS-RANDOMISED COMPARISON OF CEFTRIAXONE AND PENICILLIN

The Lancet

Volumn 331, Issue 8596, 1988, Pages 1191-1194

  Dattwyler, RaymondJ ^a   Volkman, DavidJ ^a   Halperin, JohnJ ^a   Luft, BenjaminJ ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; PENICILLIN G;

ADULT; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; CEFTRIAXONE; CLINICAL TRIALS; COMPARATIVE STUDY; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMAN; INJECTIONS, INTRAVENOUS; LYME DISEASE; MALE; MIDDLE AGE; PENICILLINS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0023894012     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)92011-9     Document Type: Article

References (32)

1. Lyme disease, a tick-borne spirochetosis?
2. Spirochetes isolated from the blood of two patients with Lyme disease
3. The spirochetal etiology of Lyme disease
4. Chronische lymphocytare Meningitis, enntzundliche Polyneuritis and "Rheumatismus"
5. Erythema chronicum migrans Afzelius with meningitis
6. Erythema chronicum migrans and Lyme arthritis
7. Lyme carditis. cardiac abnormalities of Lyme disease
8. Neurologic abnormalities of Lyme disease
9. The early clinical manifestations of Lyme disease
10. The spirochetal etiology of erythema chronicum migrans Afzelius
11. Penicillin treatment of erythema chronicum migrans Afzelius
12. Treatment of the early manifestations of Lyme disease
13. Failure of tetracycline therapy in early Lyme disease
14. Successful parenteral penicillin therapy of established Lyme arthritis
15. Lyme meningoencephalitis—report of a severe, penicillin-resistant case
16. Ceftriaxone as effective therapy in refractory Lyme disease
17. High dose penicillin in meningopolyneuritis Garin-Bujadoux-Bannwarth
18. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease
19. Cellular immune responses in Lyme disease
20. Lyme disease—cause of a treatable peripheral neuropathy
21. Antibiotic therapy in early erythema migrans disease and related disorders
22. Pencillin-resistant borrelia encephalitis responding to cefotaxime
23. vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents
24. Bj Luft, Rj Dattwyler, Jj Halperin, DJ. Volkman, New chemotherapeutic approaches to the treatment of Lyme disease, Ann NY Acad Sci ((in press)).
25. vitro and in vivo susceptibility of Borrelia burgdorfen
26. Infectious risk factors in the immunosuppressed host
27. Prognostic factors in cryptococcal meningitis